COLACI, Michele
 Distribuzione geografica
Continente #
NA - Nord America 6.202
AS - Asia 3.193
EU - Europa 2.419
SA - Sud America 503
AF - Africa 337
OC - Oceania 2
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.658
Nazione #
US - Stati Uniti d'America 5.999
SG - Singapore 1.861
RU - Federazione Russa 913
CN - Cina 746
IE - Irlanda 490
BR - Brasile 425
IT - Italia 420
VN - Vietnam 199
FR - Francia 167
CI - Costa d'Avorio 154
CA - Canada 147
NG - Nigeria 111
KR - Corea 104
UA - Ucraina 87
GB - Regno Unito 76
IN - India 63
DE - Germania 55
MX - Messico 32
BD - Bangladesh 29
AR - Argentina 28
NL - Olanda 27
IQ - Iraq 26
SE - Svezia 25
FI - Finlandia 24
HK - Hong Kong 22
PL - Polonia 22
CH - Svizzera 19
ES - Italia 18
AT - Austria 17
JP - Giappone 16
ZA - Sudafrica 16
EC - Ecuador 15
ID - Indonesia 15
SN - Senegal 14
TR - Turchia 13
UZ - Uzbekistan 13
CZ - Repubblica Ceca 11
BJ - Benin 10
GR - Grecia 10
LB - Libano 10
AE - Emirati Arabi Uniti 9
IR - Iran 9
MA - Marocco 9
PK - Pakistan 9
CO - Colombia 8
PY - Paraguay 8
SA - Arabia Saudita 8
KE - Kenya 7
LT - Lituania 7
DO - Repubblica Dominicana 6
VE - Venezuela 6
JM - Giamaica 5
MY - Malesia 5
TT - Trinidad e Tobago 5
BE - Belgio 4
CL - Cile 4
HU - Ungheria 4
JO - Giordania 4
KZ - Kazakistan 4
NP - Nepal 4
PH - Filippine 4
RO - Romania 4
TN - Tunisia 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BO - Bolivia 3
GT - Guatemala 3
IL - Israele 3
OM - Oman 3
PE - Perù 3
RS - Serbia 3
AU - Australia 2
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
LK - Sri Lanka 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HN - Honduras 1
HR - Croazia 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
MM - Myanmar 1
Totale 12.648
Città #
Singapore 1.116
Dallas 916
Santa Clara 862
Chandler 736
Dublin 490
San Jose 441
Ashburn 319
Moscow 305
Chicago 198
Houston 175
Boardman 165
Abidjan 154
New York 152
Los Angeles 132
Lauterbourg 128
Hefei 127
Lawrence 126
Cambridge 122
Andover 120
Nanjing 115
Beijing 108
Seoul 103
Catania 85
Jacksonville 83
Toronto 79
Des Moines 76
Lagos 66
Ho Chi Minh City 60
Council Bluffs 54
Hanoi 41
São Paulo 41
Wilmington 40
Civitanova Marche 35
The Dalles 35
Columbus 34
Ottawa 32
Abuja 29
Saint Petersburg 29
Shenyang 27
Jiaxing 25
Nanchang 25
Palermo 25
Buffalo 24
Orem 24
Hebei 23
Bremen 22
Falls Church 22
Ann Arbor 20
Milan 20
Hong Kong 19
Warsaw 18
Brooklyn 17
Kochi 17
Montreal 17
Chennai 16
Port Harcourt 16
Rome 16
Denver 15
Poplar 15
Tianjin 15
Atlanta 14
Dakar 14
Tokyo 14
Amsterdam 13
Belo Horizonte 13
Changsha 13
Mexico City 13
Rio de Janeiro 13
San Francisco 13
Stockholm 13
Seattle 12
Haiphong 11
Lappeenranta 11
London 11
Boston 10
Cotonou 10
Da Nang 10
Jesi 10
Johannesburg 10
Washington 10
Brno 9
Jakarta 9
Kunming 9
Norwalk 9
Nuremberg 9
Tehran 9
Guangzhou 8
Hải Dương 8
Jinan 8
Phoenix 8
Quito 8
Turin 8
Baghdad 7
Cesa 7
Frankfurt am Main 7
Manchester 7
Paterno 7
Turku 7
Bari 6
Biên Hòa 6
Totale 8.761
Nome #
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 175
COVID-19-related retinal microvasculopathy and systemic implications in patients with severe disease: results from the Methuselah study 171
Endocrine disorders associated with hepatitis C virus chronic infection 158
Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients 154
A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies 152
"Usual" interstitial pneumonia with autoimmune features: a prospective study on a cohort of idiopathic pulmonary fibrosis patients 139
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection 134
Cardiovascular risk and prostanoids in systemic sclerosis 131
Myositis-Specific and Myositis-Associated Antibodies in Fibromyalgia Patients: A Prospective Study 129
[CXCR3 and CXCL10 in autoimmune thyroiditis] 127
COMPARISON BETWEEN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES: A PROSPECTIVE COHORT 127
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection and HCV extrahepatic manifestations 126
Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them? 126
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 125
Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients 125
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 124
Aortic root dilation in associated with the reduction in capillary density observed at nailfold capillaroscopy in SSc patients 122
Aortic pulse wave velocity measurement in systemic sclerosis patients 118
ADHERENCE TO THERAPY IN RHEUMATIC PATIENTS TREATED WITH SUBCUTANEOUS BIOLOGICS 117
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature. 116
Associations between Systemic Sclerosis and Thyroid Diseases 116
Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study 115
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis. 115
Cardiac involvement in systemic sclerosis: Identification of high-risk patient profiles in different patterns of clinical presentation 114
Reduction of carotid baroreceptor sensitivity in systemic sclerosis 113
ADULT ONSET STILL'S DISEASE: A MULTICENTER RETROSPECTIVE COHORT STUDY OF 233 ITALIAN PATIENTS 113
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 112
Capillaroscopic skin ulcer risk index: A new prognostic tool for digital skin ulcer development in systemic sclerosis patients 112
Assessing Humoral Immuno-Inflammatory Pathways Associated with Respiratory Failure in COVID-19 Patients 111
The Impaired Elasticity of Large Arteries in Systemic Sclerosis Patients 108
Use of 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients affected by polymyalgia rheumatica and persistent increase of acute phase reactants 108
The Morphological Domain Does Not Affect the Rate of Progression to Defined Autoimmune Diseases in Patients With Interstitial Pneumonia With Autoimmune Features 108
Heart Valve Abnormalities in Systemic Sclerosis Patients: A Multicenter Cohort Study and Review of the Literature 108
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 107
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 106
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 106
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 99
Evaluation of changes in cardiac longitudinal strain rate in patients with systemic sclerosis undergoing iloprost treatment: an observational study 98
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 98
Pancreatic Neuroendocrine Tumor (Pan-NET) Presented by Abdominal Pain: A Case Report and Literature Review 97
Sclerosing cholangitis may mimic radiological pattern of cholangiocarcinoma: Differential diagnosis and review of literature 96
Heart involvement and systemic sclerosis 96
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 94
Effectiveness and safety of filgotinib in rheumatoid arthritis: a real-life multicentre experience 92
Etiopathogenesis of Systemic Sclerosis: Role of Human Parvovirus B19 92
Elevated Troponin Serum Levels in Adult Onset Still's Disease 91
Systemic Sclerosis and Idiopathic Portal Hypertension: Report of a Case and Review of the Literature 90
From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution 90
High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes 90
Novel Therapies for Thyroid Autoimmune Diseases 89
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis 89
Nailfold videocapillaroscopy alterations in dermatomyositis and systemic sclerosis: Toward identification of a specific pattern 89
Targeting intracellular pathways in idiopathic inflammatory myopathies: A narrative review 88
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study 88
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature 87
Vascular dysfunction of COVID-19 is partially reverted in the long-term 87
Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: A multicentre validation study 86
Impegno cardiaco nella sclerosi sistemica 85
Vasculiti sistemiche 85
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 85
Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis. 85
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 85
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 85
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 83
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 83
Paraneoplastic rheumatic disorders: a narrative review 83
The Pattern and Progression of "Usual" Interstitial Pneumonia with Autoimmune Features: Comparison with Patients with Classic Interstitial Pneumonia with Autoimmune Features and Idiopathic Pulmonary Fibrosis 82
High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ. 82
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 82
Feasibility, face, and content validity of quantitative computed tomography in interstitial lung disease related to connective tissue diseases 81
Trattamento del dolore in reumatologia con oppioidi: nostra esperienza con ossicodone in pazienti con ulcere cutanee vasculitiche. 81
IP-10 in autoimmune thyroiditis 80
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers 80
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 80
Viral infections and systemic sclerosis. 80
The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients 80
Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2. 80
HCV-related autoimmune disorders in HCV chronic infection. 80
Serum a-Chemokine CXCL10 and b-Chemokine CCL2 Levels in HCV-Positive Cryoglobulinemia 80
LONG-TERM TREATMENT WITH RITUXIMAB IN SYSTEMIC SCLEROSIS MANAGEMENT: AN OVERVIEW OF THE CLINICAL EXPERIENCE FROM A REAL-LIFE SETTING 80
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up 79
Storia naturale della sclerosi sistemica in Italia. 78
Platelet gel in the treatment of severe scleroderma skin ulcers 78
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 78
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature 77
Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report 77
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 77
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 77
The safety of iloprost in systemic sclerosis in a real-life experience 77
Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensus 77
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 77
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature 76
Lung involvement in systemic sclerosis: role of high resolution computed tomography and its relationship with other pulmonary and clinico-serological features. 76
Osteomyelitis complicating scleroderma digital ulcers 76
Severe alopecia complicating systemic sclerosis 75
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C 75
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 75
The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak 75
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 74
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers 73
Totale 9.808
Categoria #
all - tutte 45.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.224


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 0 0 0 7 8
2021/2022816 77 126 2 6 143 12 127 31 34 9 26 223
2022/20231.838 139 80 57 182 185 329 10 265 458 18 65 50
2023/2024652 47 97 30 27 25 145 3 49 7 21 136 65
2024/20253.005 22 373 170 136 645 417 91 80 269 287 310 205
2025/20265.653 354 288 992 298 1.023 1.063 789 108 309 314 115 0
Totale 12.977